Abstract
The analysis of cell free DNA is increasingly being used for the early detection of biomarkers relevant to obstetric and oncology practice. Guaranteeing the quality of these analyses is critical to retaining the confidence of the public in these tests. This chapter outlines internal and external quality control and assessment procedures open to laboratories to ensure the production of valid test results. As an example clinical test, the chapter considers non-invasive prenatal testing to determine fetal sex using cell free DNA isolated from maternal plasma. External Quality Assessment as a method through which laboratories can compare their results with a set of peers is also discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boon EM, Schlecht HB, Martin P, Daniels G, Vossen RH, den Dunnen JT, Bakker B, Elles R (2007) Y chromosome detection by real time PCR and phosphorolysis-activated polymerization using free fetal DNA isolated from maternal plasma. Prenat Diagn 27(10):932–937
Mattocks CJ, Morris MA, Matthijs G, Swinnen E, Corveleyn A, Dequeker E, Müller CR, Pratt V, Wallace A; EuroGentest Validation Group (2010) A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet 18(12):1276–1288
White HE, Dent CL, Hall VJ, Crolla JA, Chitty LS (2012) Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of non invasive prenatal diagnosis. PLoS One 7(9):45073
Metcalfe P, Rigsby P, Tait E, Urbaniak S (2011) An International reference reagent for the detection of RHD and SRY DNA in plasma. Vox Sang 102(3):243–249
Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE (2001) Quality control in molecular genetic testing. Nat Rev Genet 2(9):717–723
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Elles, R., Patton, S., Kamarainen, O., Deans, Z. (2015). Quality Assurance. In: Gahan, P. (eds) Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring. Advances in Predictive, Preventive and Personalised Medicine, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9168-7_13
Download citation
DOI: https://doi.org/10.1007/978-94-017-9168-7_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9167-0
Online ISBN: 978-94-017-9168-7
eBook Packages: MedicineMedicine (R0)